← Back to Search

Vision Therapy for Intermittent Exotropia (VT-IXT Trial)

Q: Are there multiple medical centers currently conducting this clinical trial?

<p>Salus University in Philadelphia, <a href="https://www.withpower.com/clinical-trials/pennsylvania">Pennsylvania</a>; Stanford University in Stanford, <a href="https://www.withpower.com/clinical-trials/ohio">Ohio</a> and Ohio State University in Columbus, <a href="https://www.withpower.com/clinical-trials/tennessee">Tennessee</a> are some of the 6 medical facilities administering this trial.</p>

N/A

Recruiting

Research Sponsored by Southern California College of Optometry at Marshall B. Ketchum University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 8 - 16 years

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 21 weeks

Awards & highlights

VT-IXT Trial Summary

This trial is testing whether vision therapy can help control a type of eye misalignment. The results will help determine whether to do a longer trial testing the therapy.

Who is the study for?

This trial is for kids aged 8-16 with a specific eye alignment issue called intermittent exotropia, where one eye occasionally drifts outward. They should have certain levels of control over their eye movement and good depth perception. Kids who plan to move soon or can't commit to the study's process are not eligible.Check my eligibility

What is being tested?

The study tests if vision therapy can help manage intermittent exotropia better than just watching the condition without treatment. Participants will be randomly assigned to either receive vision therapy or be observed, helping decide if more extensive research is needed.See study design

VT-IXT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 8 and 16 years old.

VT-IXT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 21 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~21 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 21 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean Distance Control Score

Secondary outcome measures

Change in Distance Control

No Spontaneous Tropia

Other outcome measures

Change in Vergence and Accommodative Measures

Objective Eye Movement Recordings

Suppression Status

VT-IXT Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Vision TherapyExperimental Treatment1 Intervention

Participants will receive 20 consecutive weeks of office-based vision therapy with home therapy.

Group II: ObservationActive Control1 Intervention

Participants will receive no treatment for IXT is received during the study unless one of the deterioration criteria is met.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Southern College of OptometryOTHER

4 Previous Clinical Trials

212 Total Patients Enrolled

Case Western Reserve UniversityOTHER

299 Previous Clinical Trials

259,962 Total Patients Enrolled

Salus UniversityOTHER

14 Previous Clinical Trials

899 Total Patients Enrolled

2 Trials studying Intermittent Exotropia

100 Patients Enrolled for Intermittent Exotropia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any limitations on the number of participants accepted into this experiment?

"In order to fulfil the desired participant quota, 58 individuals that fit this study's inclusion criteria must be recruited. Salus University in Philadelphia, Pennsylvania and Stanford University in Stanford, Ohio are two of many sites offering enrolment for this trial."

Answered by AI

Are there multiple medical centers currently conducting this clinical trial?

"Salus University in Philadelphia, Pennsylvania; Stanford University in Stanford, Ohio and Ohio State University in Columbus, Tennessee are some of the 6 medical facilities administering this trial."

Answered by AI

What are the eligibility criteria for this research study?

"To be considered for this trial, applicants must have intermittent exotropia and fall between 8-16 years of age. The total number of desired participants is 58."

Answered by AI

Are there any current opportunities for participants to join this experiment?

"Affirmative. Documentation on clinicaltrials.gov shows that this experiment, first posted October 1st 2021 is currently looking for participants. 58 candidates need to be recruited across 6 centres and the trial was last updated May 19th 2022."

Answered by AI